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Objectives: Currently, the survival for the Norwood procedure for hypoplastic left
heart syndrome is approximately 90% in selected centers. However, the develop-
ment of tricuspid regurgitation remains a significant obstacle to successful staged
repair in a subset of these patients. The results of tricuspid valve repair in this
challenging patient population remain largely unknown.
Methods: Twenty-eight patients with significant (3-4) tricuspid regurgitation after
the Norwood procedure required tricuspid valve repair from August 1995 through
December 2002. The clinical and Doppler-echocardiographic data were reviewed to
determine the efficacy of repair and patient outcome.
Results: Follow-up was 96% complete (27/28). Patients were divided into 2 groups
on the basis of tricuspid regurgitation at late follow-up: those with a successful late
outcome (0-2) and those with a poor outcome (3-4). There were 17 (63%)
patients with a successful result and 10 (37%) with an adverse outcome. Age,
weight, follow-up duration, valve anatomy, and stage of palliation were not signif-
icantly different between groups. Early postoperative 0 to 2 regurgitation was
associated with a durable result (P  .012) and preserved ventricular function (P 
.04). Need for repair other than a partial annuloplasty was predictive of a poor
outcome (P .04). Overall survival was 67% (18/27). Survival was 94% (16/17) for
patients with a successful late result versus 20% (2/10) for those with a poor
outcome (P  .0002).
Conclusions: Tricuspid valve repair can be accomplished in this challenging patient
population with excellent results. Successful tricuspid valve repair is predictive of
continued good valve function and preserved right ventricular function. Successful
valve repair at late follow-up predicts excellent late survival.
The outlook for patients with hypoplastic left heart syndrome (HLHS)has dramatically improved over the past 2 decades. Universally fatalonly 25 years ago, outcomes for staged palliation have shownconsistent improvement since that time. Hospital survivals as high as93% have recently been reported for the Norwood procedure.1However, attrition rates after the Norwood procedure remain signif-
icant, with mortalities of 4% to 15% reported between the first 2 stages alone.1-4
Five-year survivals for HLHS, even at centers reporting the best Norwood procedure
outcomes, remain approximately 75%.1,5 In addition to the deaths, some patients are
unable to progress through the 3 stages of reconstruction and might require cardiac
transplantation or have no options for further therapy. There are many causes for
these mortalities and morbidities after the Norwood procedure. These factors
include increased pulmonary vascular resistance, cardiac arrhythmia, coronary
artery insufficiency, right ventricular (RV) failure, RV volume overload caused by
shunt-dependent physiology, and tricuspid valve regurgitation (TR). Many of these
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factors are interrelated and might form feedback loops,
which serve to propagate their adverse effects on patients
with HLHS (Figure 1).
TR is of particular interest because it is one potential area
in which surgical intervention might improve outcomes. TR
might be due to an intrinsic abnormality of valve anatomy,
or it might be due to any of the factors outlined above, such
as RV dysfunction or dilatation. In addition, the morpho-
logic tricuspid valve is subjected to systemic pressure rather
than pulmonary workloads. Because of the multifactorial
nature of the cause of TR, simple repair of the valve might
not address the underlying problem and hence fail to im-
prove the TR or patient outcome. To address this issue, we
performed a retrospective review of all patients undergoing
a tricuspid valve repair to assess early and late outcome, as
well as procedural and anatomic variables predictive of
successful repair.
Methods
Study Design
A retrospective analysis was performed on all patients with HLHS
undergoing a tricuspid valve repair after a Norwood operation to
determine the results of tricuspid valve repair in HLHS. The study
hypothesis was that tricuspid valve repair is an effective means of
treating TR in patients with HLHS. The primary end point was the
degree of TR present at last follow-up, irrespective of nonvalve-
related death or transplantation. Tricuspid regurgitation was char-
acterized on a 0 to 4 grading scale, which is similar to that
commonly used for mitral regurgitation. The grading scale was
defined as follows: 0, none; 1, mild (narrow regurgitant jet at the
orifice [2 mm], single jet); 2, mild to moderate (wider jet area
at orifice [4 mm], multiple jets, or both, mild atrial enlargement);
3, moderate to severe (wide jet orifice, jet reaches back wall of
atrium, moderate atrial enlargement); and 4, severe (wide jet
orifice, jet reaches back wall of atrium, reversal of flow in the
pulmonary or hepatic veins, severe atrial enlargement). A success-
ful outcome was defined as 0 to 2 TR and an adverse outcome as
3 to 4 TR or need for valve replacement. RV function was
graded on a subjective scale as normal, mildly decreased, moder-
ately decreased, and severely decreased. The valve anatomy re-
sponsible for the TR, such as leaflet prolapse or leaflet tethering,
was noted. The diameter of the tricuspid valve, expressed as a z
value, was also recorded for all patients by using standard calcu-
lations to assess the degree of annular dilatation.6 These variables
(degree of TR, RV function, valve anatomy, and tricuspid valve z
value) were assessed preoperatively, at discharge after repair, and
at latest follow-up. A single echocardiographer reviewed all echo-
cardiograms.
Secondary aims involved comparing the groups with a success-
ful and unsuccessful result as defined above. Variables for com-
parison included patient demographics, valve anatomy, operative
technique, RV function, and immediate postoperative result. The
other secondary aims were to evaluate the durability of successful
repair and survival.
Patients
From August 1994 through December 2002, 475 patients with
HLHS underwent operations at the C. S. Mott Children’s Hospital
of the University of Michigan Health System. Of these operations,
28 had undergone a tricuspid valve repair for greater than 2 TR
after a Norwood procedure. In general, valve repair was under-
taken for the presence of 3 to 4 TR, regardless of symptoms, to
optimize the patient’s hemodynamics and preserve RV function.
Only patients with classic HLHS, as defined by right ventricle–
dependent systemic circulation and atresia or hypoplasia of the
aortic valve, were enrolled. Patient demographics recorded in-
cluded age at repair, weight at repair, stage of palliation, and length
of follow-up. Surgical variables include type of repair, concomi-
tant procedures, and operative morbidity or mortality.
Surgical Techniques
Surgical techniques were individualized to the patient’s valve
pathology on the basis of the opinion of the operating surgeon.
Standard methods of cardiopulmonary bypass were used, with
initial examination of the tricuspid valve performed by filling the
right ventricle with saline. Intraoperative determination was made
of the location or locations of regurgitation, the diameter of the
annulus, leaflet prolapse, and leaflet tethering. Coupled with the
preoperative echocardiogram, intraoperative echocardiogram, or
both, appropriate methods of repair were then selected. Partial
annuloplasty was commonly applied for patients with anterior
leaflet prolapse or annular dilatation with failure of leaflet coap-
tation and generalized central regurgitation. This technique in-
Figure 1. The relationships between factors negatively affecting mortality and morbidity in HLHS. PVOD, Pulmo-
nary vascular obstructive disease.
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volves running parallel mattress sutures along the annulus from the
anteroposterior commissure to the posteroseptal commissure (Fig-
ure 2). The annuloplasty essentially obliterates the posterior leaflet,
forming a bicuspid valve. Localized areas of leaflet prolapse were
repaired by using partial commissure closure, and individual clefts
or defects in the leaflets were closed primarily (Figure 3). Ring
annuloplasty was also used, with a flexible partial ring. Less
frequently used techniques included chordal shortening (n  3),
papillary muscle advancement (n  1), and mobilization of the
septal leaflet (n  1). The techniques were not mutually exclusive,
and any individual patient might have undergone more than one
repair method.
Statistical Analysis
Differences in dichotomous variables were compared by using the
Fisher exact test. Wilcoxon rank sum tests were performed to
compare the differences in ordinal variables, such as TR and RV
dysfunction. TR in the postoperative period was dichotomized to
2 TR or less and greater than 2 TR. The sensitivity, specificity,
positive predictive value, and negative predictive value were then
calculated for the finding of postoperative TR of greater than 2.
Results
Patients
Of the 28 patients who underwent a tricuspid valve repair
for significant TR after a Norwood procedure, 27 (96%)
were available for follow-up. Median follow-up for the
entire group was 20 months (range, 1-82 months). The
patients were subsequently divided into groups on the basis
of whether they had a successful late outcome, as defined by
0 to 2 TR at last follow-up, or an adverse outcome, as
defined by 3 to 4 TR. Seventeen (63%) patients were
found to have had a successful outcome at a median fol-
low-up of 26 months (range, 1-82 months). Ten (37%)
patients had a poor outcome at a median follow-up of 13
months (range, 1-75 months). Median age at repair, weight
at repair, stage of palliation, tricuspid valve pathology, and
length of follow-up were found not to be significantly
different between the 2 groups (Table 1). Patients in the
unsuccessful outcome group tended to require repair earlier
in their palliation. Sixty-five percent (11/17) of patients in
the success group achieved at least the hemi-Fontan proce-
dure before requiring tricuspid valve repair compared with
only 30% (3/10) in the failure group (P .12). Concomitant
tricuspid valve repair and either the hemi-Fontan procedure
or the Fontan procedure were common in both groups
(Table 2). In the group achieving a successful late result, 6
of 9 patients who were at the hemi-Fontan procedure stage
at the time of their tricuspid valve repair were able to
undergo a successful concomitant Fontan procedure.
Repair Technique
Partial annuloplasty, used in 17 patients, was the most
frequently used repair technique. Partial commissure clo-
Figure 2. Partial annuloplasty.
Figure 3. Partial commissure closure and leaflet cleft repair.
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sure for localized areas of leaflet prolapse was used in 6
patients. Ring annuloplasty was performed in 5 patients
with a median ring size of 28 mm (range, 25-31 mm).
Chordal shortening was used in 3 patients, and papillary
muscle advancement and mobilization of the septal leaflet
were used in 1 patient each. The repair technique of partial
annuloplasty alone, when compared with any other method
or combination of methods, significantly predicted 0 to 2
TR at late follow-up (P  .04, Figure 4).
Tricuspid Valve Regurgitation
All patients had 3 to 4 TR before the operation. There was
no difference between the tricuspid valve pathology primar-
ily responsible for the regurgitation, as assessed by means of
2-dimensional and Doppler echocardiography (Table 3).
Similar degrees of tricuspid valve annulus dilatation were
seen in both groups preoperatively, early postoperatively,
and at late follow-up. However, in both groups the median
z value decreased after the valve repair. The z value then
tended to stay stable in the late success group, whereas it
increased slightly in the group with late failure (Figure 5).
After tricuspid valve repair, 21 patients had an early suc-
cessful result as defined by 0 to 2 TR in the immediate
postoperative period. Of these 21 patients, 15 maintained a
durable repair at late follow-up, and 6 had late failure. Six
patients had an early unsuccessful repair, 4 of whom con-
tinued to have a poor result at late follow-up. The remaining
2 patients with an unsuccessful repair in the early postop-
erative period underwent rerepair with a successful late
outcome (Figure 6). Early successful repair was predictive
of late success (P  .012), with a sensitivity of 76%, a
specificity of 70%, a positive predictive value of 81%, and
a negative predictive value of 64%.
RV Function
All patients had similar RV function preoperatively, with a
median functional grading of normal, ranging from normal
to mildly decreased. There was no significant difference
TABLE 1. Nonsignificant variables
Variable
Late outcome
P value0–2 TR 3–4 TR
Median age, mo (range) 20 (5–56) 4 (4–127) .32
Median weight, kg (range) 8.7 (4.5–18.7) 6.1 (4.9–35.6) .24
Median follow-up, mo
(range)
26 (1–82) 13 (1–75) .08
Predominant valve pathology
(leaflet prolapse-tethering)
15/2 7/3 .33
Comparison of variables between patients achieving a successful late
result and those with a poor late result.
TR, Tricuspid valve regurgitation.
TABLE 2. Concomitant procedures performed with tricus-
pid valve repair
Concomitant procedure
Late outcome
0–2 TR 3–4 TR
Hemi-Fontan 6/17 (35%) 7/10 (70%)
Fontan 6/17 (35%) 1/10 (10%)
TR, Tricuspid valve regurgitation.
Figure 4. Repair techniques: comparison of patients with a suc-
cessful outcome and an adverse outcome, revealing a significant
difference between partial annuloplasty alone and the need for
any other repair technique or combination of techniques (P 
.04).
TABLE 3. Primary valve pathology as assessed by means
of echocardiography (P  not significant)
Valve pathology
Late outcome
0–2 TR 3–4 TR
Leaflet prolapse 15/17 (88%) 7/10 (70%)
Leaflet tethering 2/17 (12%) 3/10 (30%)
TR, Tricuspid valve regurgitation.
Figure 5. Tricuspid valve z values: comparison of preoperative,
early postoperative, and late tricuspid valve z values between the
late success and failure groups.
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between the late success group and the late failure group
with respect to the early postoperative or late follow-up RV
function. Although differences failed to reach statistical
significance, interesting trends were noted when comparing
the groups. These trends were particularly apparent when
comparing the 4 groups with early postoperative success
and late follow-up success, early success and late failure,
early failure and late success (because of successful rere-
pair), and early failure and continued late failure, as outlined
in Figure 6. Those patients with early success and continued
late success of repair (Figure 7, A) had preserved RV
function both early postoperatively and at late follow-up.
Similarly, those patients with an early failure who were
salvaged with a rerepair to a successful late outcome (Figure
7, B) had preserved RV function throughout. Conversely,
patients with an early success but late failure (Figure 7, C)
had poor RV function, even in the early postoperative
period, which was persistent at late follow-up. The last
group, those patients with both early and late failure (Figure
7, D), initially had preserved RV function in the early
postoperative period, which deteriorated at late follow-up.
Patient Outcomes and Survivals
Of the 17 patients with a successful repair at late follow-up,
15 had achieved their Fontan repair (Figure 8, A). Among
this group, there were 14 long-term survivors and 1 death.
The death was a witnessed sudden death in a patient with
1 TR and mild-to-moderate RV dysfunction 2 years after
his Fontan operation. Two patients were at a hemi-Fontan
stage, one of whom is awaiting his Fontan operation and is
considered to be a good Fontan candidate. The other patient
underwent a cardiac transplantation for diastolic dysfunc-
tion with normal RV systolic function and minimal TR.
There were 10 patients with an unsuccessful repair at late
follow-up (Figure 8, B). There were 8 deaths in this group.
Two deaths were early operative mortalities, one caused by
an intraoperative coronary artery injury and the other by
postoperative RV failure. There were 6 late deaths, all of
which had required an attempted rerepair or mechanical
valve replacement. Two of the 10 patients in this group are
late survivors, both of whom have achieved a successful
Fontan procedure. One patient has a mechanical prosthetic
valve. The other patient has had a single repair with residual
3 TR, has normal RV function, and remains in New York
Heart Association (NYHA) class I.
Overall survival for the entire cohort was 67% (18/27).
For patients with a successful late repair, survival was 94%
(16/17). In contrast, patients with 3 to 4 TR at follow-up
had a survival of 20% (2/10), a difference that was statis-
tically significant (P .0002). With respect to RV function,
Figure 6. Diagram of the early and late TR after repair. The
number of patients in each group and the number of patients
crossing over between groups are indicated.
Figure 7. RV function. Scale: 4, normal; 3, mildly decreased; 2,
moderately decreased; 1, severely decreased. Groups: A, early
success/late success; B, early failure/late success; C, early fail-
ure/late failure; D, early success/late failure.
Figure 8. Outcomes of the patients with successful late repair (n
 17, A) or unsuccessful late repair (n  10, B).
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comparison of the survivals of those patients with normal to
mildly decreased function (86% [18/21]) and those with
moderate-to-severe dysfunction (0% [0/6]) similarly re-
vealed a significant difference in survival (P  .0003). Of
the 18 late survivors, 17 are in NYHA class I, and 1 is in
NYHA class II.
Study Limitations
The limitations of this study are primarily related to the
retrospective nature of the analysis and to the limited num-
ber of patients. In addition, the complex and multifactorial
nature of TR in HLHS makes defining the specific variables
responsible for the outcomes of repair and other late out-
comes difficult.
There is also a risk of selection bias because there might
have been patients with severe TR who were not captured.
Although cardiac transplantation for severe TR and severe
RV was accounted for, it is possible that other patients
might not be included in this cohort. These patients might
have had significant TR and RV dysfunction and died at
home or had other surgical intervention or died at outside
institutions.
Discussion
Tricuspid Valve Repair
Overall, these data demonstrate that tricuspid valve repair
can be successfully accomplished in the majority of patients
with HLHS, even in the face of severe TR. Repair can be
performed as a sole procedure or in conjunction with a
hemi-Fontan or Fontan procedure. Successful repair in the
early postoperative period is significantly predictive of con-
tinued excellent valve function and preserved RV perfor-
mance at late follow-up. Partial annuloplasty was found to
be significantly associated with a successful late outcome.
However, partial annuloplasty might be a surrogate for other
factors, which were not detected. These factors might in-
clude variables, such as fine differences in tricuspid valve
anatomy not delineated by echocardiography, subclinical
RV dysfunction, or subtle coronary artery insufficiency.
Several different repair techniques were successfully used,
and the method of repair should be individualized to the
particular anatomy encountered. Similarly, the trend toward
earlier operation in the group with an unsuccessful late
outcome likely represents a surrogate for a worse subgroup
of TR that tends to present earlier, rather than an indication
that repair should be delayed at all costs.
Interaction of TR and RV Function
TR, particularly in the setting of HLHS, is the result of
several complex and interrelated variables. RV function
appears to be one of the variables that has an important role
in the natural history of tricuspid regurgitation. When com-
paring patients with a successful early postoperative result
that either continued to have 0 to 2 TR or went on to late
failure, those patients who maintained a successful repair
had significantly better RV function.
However, the contribution of any given factor, such as
RV function, to the development of TR is likely variable
from patient to patient. This variable influence of RV func-
tion on TR might be illustrated by trends that were demon-
strated in comparing the early postoperative results with the
late outcomes of the various groups. Patients with both an
early postoperative and late successful outcome had pre-
served RV function throughout the period of follow-up.
Similarly, patients with an initial unsuccessful repair who
achieved a successful late result with rerepair also had
preserved RV function, both demonstrating the importance
of RV function in tricuspid valve competence. In contrast,
patients with an early successful repair followed by late
failure had more decreased RV function in both early and
late follow-up, suggesting that RV dysfunction might have
played an important role in the late deterioration of tricuspid
valve function. Conversely, in patients with poor tricuspid
valve competence both immediately after repair and at late
follow-up, RV function was initially preserved and later
decreased, implying an adverse effect of TR on RV func-
tion.
Survival and Outcomes
Despite remarkable improvements in survivals for HLHS
over the past 2 decades, interstage and 5-year mortality
remains significant.1-5 An important factor in this ongoing
attrition is the development of significant TR, which has
been reported to occur in from 8.5% to 16% of patients with
HLHS.7,8 In a previous publication from our institution,9
14% of patients had 2 TR or greater after a Norwood
procedure for HLHS. TR has long been recognized as a risk
factor for Fontan procedure survival and has even been
suggested as a relative contraindication to pursuing stage
palliation for HLHS.7,8,10 However, tricuspid valve repair
can be successfully performed and contributes to improved
outcomes. Overall, the percentages of patients progressing
to a successful Fontan procedure and the overall survivals
after tricuspid valve repair are excellent in this very high-
risk subpopulation of patients with HLHS.
Patients with an initially successful repair but poor RV
function tended to do poorly as a group because deteriorat-
ing tricuspid valve function often developed. Patients with
an initially poor result for repair but preserved RV function
can achieve a good result with a rerepair. However, when
RV dysfunction develops over time in those patients with
residual TR, the prognosis is poor. The poor outcome asso-
ciated with the latter subgroup suggests that these patients
might benefit from early consideration for cardiac transplan-
tation.
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Discussion
Dr Thomas L. Spray (Philadelphia, Pa). I am pleased to have
the opportunity to discuss this excellent and timely contribution
from Dr Ohye and his colleagues at the University of Michigan.
Obviously, as he mentioned, as success rates for staged reconstruc-
tion for HLHS continue to improve, the problems that affect
long-term outcome, such as TR, are gaining increasing importance.
The authors have made an excellent attempt to study the effects of
valve repair for TR after the Norwood operation for HLHS, with
results that are good considering the fact that the patient population
is quite diverse. As in most excellent and timely series, however,
there are many questions stimulated by their discussion that I think
will require ongoing investigation. I have several questions for the
authors.
First, the authors described a series of 28 patients who had
significant TR and underwent valve repair, but in other studies
from their own institution, they reported an incidence of 14% of
significant valve regurgitation after the Norwood operation. That
would suggest that there are a large number of patients not repre-
sented in this series who have significant TR and yet did not
undergo valve repair. I wonder if you could comment on the
clinical criteria that you used to determine the timing of tricuspid
repair and which patients really seemed to be appropriate for the
procedure?
Was severe TR associated with stage I reconstruction or with
recurrent arch obstruction, for example, in your series? Were there
other clinical criteria that forced you to intervene with tricuspid
repair? This is especially important because, as you noted, one of
your patients who underwent a failed repair actually did well in
follow-up, with good ventricular function and a Fontan procedure.
Therefore why do you repair these valves, and how important is it
to repair them?
Second, our own experience would suggest that moderate or
greater TR that is present at birth or immediately after the first-
stage reconstruction presages a very poor long-term outcome. I
wonder if you have had a similar experience and if you could
comment on that.
And finally, our own experience suggests that you get improve-
ment in atrioventricular valve function at the hemi-Fontan proce-
dure just from volume unloading of the ventricle, and I noted in
your article and in your series that several patients underwent
valvuloplasty at the time of the hemi-Fontan or second-stage
operation. Do you think that valve repair should be performed in
all patients with significant TR at the second operation, or would
you allow some patients to volume unload and see whether their
TR improves?
Dr Ohye. Thank you for your comments, Dr Spray. To address
your first comment about the 14% presented in a previous article
from our institution, those patients had greater than or equal to 2
TR, and we limited our patients only to those with 3 to 4 TR. The
range in the literature for “significant” TR ranges from about 8.5%
to 16%, and therefore these patients should represent a good
capture of the cases of significant, or 3 to 4, TR.
As to the question regarding the time of presentation of TR and
the indications and timing of repair, because these patients had 3
to 4 TR, the repair was mandated by the presence and degree of
TR. None of these patients had 2 TR or less and would have been
considered for expectant management with hopes of improvement
with the reduction in volume overload associated with additional
staged palliation. Of the patients who were at their Norwood stage,
which were 15 patients, all underwent a concomitant hemi-Fontan
procedure. At the time of the detection of their TR (before hemi-
Fontan work-up), they would require some procedure to improve
their pulmonary blood flow. The options would be either to reshunt
them and do a repair or do a hemi-Fontan procedure and repair. We
have selected to perform a concomitant hemi-Fontan procedure
because, as you pointed out, volume offloading the ventricle at the
hemi-Fontan procedure might, in fact, help. Of the patients who
were at their hemi-Fontan stage, which included 10 patients, 7
underwent a successful concomitant Fontan procedure.
Thus in terms of timing, repair was mandated in this population
by the fact that they had significant TR. Because of the fact that we
only selected those patients with 3 to 4 TR, I believe there is
little argument that they would not have done well without repair.
We did not limit progression to further palliative stages in patients
who were otherwise good anatomic and hemodynamic candidates
on the basis of the presence of TR.
We have also found that the patients who present at birth with
3 to 4 TR are a very difficult group of patients. Those patients
with 3 to 4 TR are also considered for transplantation at that
stage rather than a Norwood operation. However, this study only
addressed patients with 3 to 4 TR after a successful Norwood
operation.
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In regard to volume unloading at the second stage, again, I
would reiterate that these patients had 3 to 4 TR, and we would
not be comfortable simply doing a hemi-Fontan procedure with
expectant management. I believe that TR does get better somewhat
with volume overloading, but that is really not sufficient to address
TR of the significance present in these patients.
Dr Jan M. Quaegebeur (New York, NY). I have a question
about the timing of the tricuspid valve repair. In your abstract the
mean age is 24 months. In our experience, when patients have
tricuspid valve incompetence, it is present very early in their
disease process, and we would tend to perform these repairs at the
age of 6 months. So why do you think that there is such a scatter
from young patients to quite older patients when you did these
repairs, and what are your present recommendations?
Dr Ohye. Our recommendations are that the valves need to be
repaired when the TR is significant, regardless of age of stage of
palliation. I believe our patients presented throughout their course
of staged repair because of the multifactorial nature of the disease.
Some patients have intrinsic valve abnormalities and might present
earlier, as Dr Spray said, even at the time of birth. Some of these
patients might have TR as a result of their ventricular dysfunction
and then tend to present later.
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